Financhill
Back

Recursion Pharmaceuticals Vs. iBio Industry Stock Comparison

Sell
44

RXRX
Recursion Pharmaceuticals

Last Price:
5.70
Seasonality Move:
6.36%
Sell
36

IBIO
iBio

Last Price:
2.64
Seasonality Move:
-11.6%
Sell
44
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $5.75. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $2.45. The Score for IBIO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $5.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $2.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: -4487806 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.21 - 7.15) Sell
Bollinger Bands (100): (6.27 - 7.63) Sell

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 49.63 Sell
Chaikin Money Flow: 139651 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.34 - 2.84) Sell
Bollinger Bands (100): (1.85 - 2.55) Buy

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.52 Sell
20-day SMA: 6.7 Sell
50-day SMA: 6.63 Sell
200-day SMA: 8.34 Sell
8-day EMA: 6.34 Sell
20-day EMA: 6.58 Sell
50-day EMA: 6.71 Sell
200-day EMA: 7.7 Sell

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.29 Buy
20-day SMA: 2.52 Sell
50-day SMA: 2.41 Buy
200-day SMA: 2.02 Buy
8-day EMA: 2.33 Buy
20-day EMA: 2.44 Buy
50-day EMA: 2.4 Buy
200-day EMA: 3.89 Sell

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):